funding-eu EU Horizon Europe HORIZON-HLTH-2026-02 HORIZON-HLTH-2026-02-DISEASE-12 Anticancer therapy Biobanks Biomarkers European Partnership on Rare Diseases (ERDERA) (Phase 2) EU — Italia · scadenza 15/09/2026
